The KIT gene helps certain cells receive growth signals, especially cells involved in blood formation, skin and hair pigment, fertility, and the nerves that coordinate movement in the gut. If this gene does not work properly, some people may have patches of lighter skin or hair, while other variants can make cells grow too strongly and are linked to conditions such as gastrointestinal stromal tumors, mastocytosis, and some blood cancers. This gene plays an important role in how your body replaces specialized cells over time.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or guiding processes in the body. Some genes carry the information needed to make proteins, which are the working parts of cells. Other genes mostly help regulate when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in the LearnHub.
Overview
KITGene function
What if the gene works
The KIT gene helps certain cells grow, survive, and communicate. It is especially important for pigment cells, blood-forming cells, reproductive cells, and special gut cells that help move food along.
Risk
What if the gene does not work
KIT gene variants often affect pigment cells, causing piebaldism with lighter skin or hair patches. Other variants can drive abnormal cell growth, including gastrointestinal stromal tumors or mast cell disease. Effects range from mild to more severe.
Treatment
What does that mean for your treatment
Some pathogenic variants in the KIT gene can guide targeted treatment. In gastrointestinal stromal tumors, exon 11 variants often respond to imatinib, while some exon 9 variants may need a different approach, and the KIT D816V variant is usually resistant to imatinib but can support use of avapritinib in advanced systemic mastocytosis. Loss-of-function variants in the KIT gene do not have a KIT-specific drug treatment.
Conditions associated with KIT
Gene function
What if the gene works
Some of your body's most active cell groups rely on the KIT gene for everyday signaling. It helps cells respond to stem cell factor, a natural growth signal, so they can grow, survive, or move when needed. Understanding what the KIT gene does helps explain how blood cells, pigment cells, reproductive cells, mast cells, and parts of the digestive tract work normally.
Cells use the protein made from the KIT gene to sense stem cell factor, a natural growth signal. This helps certain cells get clear instructions to grow, stay alive, or move to the right place.
It supports early blood-forming cells in the bone marrow, the soft center of bones. This helps your body keep making new blood cells as older ones wear out.
The KIT gene also helps mast cells mature and survive in tissues. Mast cells are immune cells that take part in allergy responses and help the body react to injury or infection.
It guides pigment-making cells as they develop and travel to the skin and hair. This supports normal coloring in the skin, hair, and parts of the eye.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help account for normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
How variants in the KIT gene affect cell signaling depends on the type of change. Some variants switch the receptor on too easily, while others reduce folding, stability, delivery to the cell surface, or signal sending. Loss-of-function changes range from milder variants with partial activity to more severe variants with little or none, which can influence how strongly KIT-related features appear and, in some cases, how early they start.
How variants are linked to conditions
Pathogenic variants in the KIT gene are linked to a few established conditions. Inherited variants in the KIT gene can cause piebaldism, a condition with patches of lighter skin and hair, and some families have gastrointestinal stromal tumors caused by variants in the KIT gene. Acquired variants in tumor cells are also common in gastrointestinal stromal tumors and are seen in systemic mastocytosis, so KIT gene variants linked to conditions can be inherited or arise only in the affected tissue.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a part. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific outside factors that clearly increase or reduce health risks linked to the KIT gene. For many living with a KIT change, risk depends most on the exact variant and the condition it is tied to, while day-to-day habits are not known to meaningfully change that inherited risk.
Inheritance of KIT variants
KIT gene variants are usually inherited in an autosomal dominant pattern. This means a parent carrying a disease causing KIT variant has a 50% chance in each pregnancy of passing it on to a child. In families asking how KIT gene variants are inherited, this is the main pattern seen for well-established KIT-related conditions such as piebaldism and some inherited tumor predisposition syndromes. Some cases happen because of a new de novo variant, so the change is not inherited from either parent.
What does my KIT result mean for my family?
For well-established inherited KIT-related conditions, the pattern is usually dominant, which means close relatives such as a parent, brother, sister, or child may also carry the same change. Each child of someone with a disease-causing KIT variant can have a 50% chance of inheriting it. Some KIT changes can happen for the first time in one family member, so a parent does not always have to be the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for the KIT gene looks for DNA variants in a blood, saliva, or tissue sample using laboratory sequencing. KIT gene genetic testing can help confirm or rule out inherited changes or changes linked to some cancers, but results need careful interpretation because not every variant affects health.
When should I consider getting a genetic test?
Genetic testing for the KIT gene may be worth discussing if you or close relatives have piebaldism, a lifelong pattern of white skin or hair patches, or certain rare digestive tract tumors called gastrointestinal stromal tumors. It can help show whether the condition is inherited and whether other family members may also carry the same gene change.
A genetic result is only one part of your health story
A genetic result may provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles certain medicines and how strongly you respond to them. This helps explain why the same treatment works well for one person, causes more side effects in another, or seems to have little effect in someone else. Differences in genes involved in drug breakdown, drug transport, or the medicine’s target are common and can influence both how well a treatment works and how sensitive you are to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medication. It studies connections between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how the body processes a drug or how strongly that drug works. This information can help support treatment decisions that are more informed and more individualized. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the KIT gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in routine medication decisions, so general questions about side effects or how well a medicine is working are best discussed with your doctor. In cancer care, KIT changes found in a tumor can sometimes help guide use of certain targeted treatments, so people living with a KIT-related cancer may want to bring this up with their oncology team.
History
The KIT gene entered medical research through cancer studies in the 1980s, when scientists linked it to a viral cancer gene called v-KIT. Soon after, researchers identified the human version and connected it to both inherited pigment differences and certain tumors. Initially understood only through visible traits, later recognized as tied to a specific gene, KIT became an important example of how one gene could be relevant in very different parts of medicine. In the 1990s, findings tied the KIT gene to piebaldism, a condition that causes patches of lighter skin and hair from birth. A major turning point came when KIT changes were found in many gastrointestinal stromal tumors, helping guide the later use of targeted treatment. These historical steps shaped today’s understanding.